Edoxaban may be effective treatment for atrial fibrillation after transcatheter aortic valve replacement

The anticoagulant edoxaban may be just as effective as warfarin for preventing heart attack or stroke in patients with atrial fibrillation (AF) who undergo transcatheter aortic valve replacement (TAVR), according to a large-scale international study led by Mount Sinai.  

source https://medicalxpress.com/news/2021-08-edoxaban-effective-treatment-atrial-fibrillation.html